The Yin and Yang of IFN-γ in allograft rejection

American Journal of Transplantation

Volumn 3, Issue 8, 2003, Pages 913-914

  Fairchild, Robert L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ALLOGRAFT; CYTOKINE PRODUCTION; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; KNOCKOUT GENE; KNOCKOUT MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN FUNCTION; REVIEW;

GRAFT REJECTION; HUMANS; INTERFERON TYPE II; TRANSPLANTATION, HOMOLOGOUS;

EID: 0041764539     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00173.x     Document Type: Review

References (13)

1. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-γ. Annu Rev Immunol 1997; 15: 749-795.
2. Nagano H, Mitchell RN, Taylor MK, Hasegawa S, Tilney NL, Libby P. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 1977; 100: 550-557.
3. Tellides G, Tereb DA, Kirkiles-Smith NC et al. Interferon-γ elicits arteriosclerosis in the absence of leukoctyes. Nature 2000; 403: 207-211.
4. Konieczny BT, Dai Z, Elwood ET et al. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998; 160: 2059-2064.
5. Halloran PF, Afrouzian M, Ramassar V et al. Interferon-γ acts directly on rejection renal allografts to prevent graft necrosis. Am J Pathol 2001; 158: 215-226.
6. Halloran PF, Miller LW, Urmson J et al. IFN-γ alters the pathology of graft rejection: protection from early necrosis. J Immunol 2001; 166: 7072-7081.
7. Miura M, El-Sawy T, Fairchild RL. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-γ. Am J Pathol 2003; 162: 509-519.
8. Wang H, DeVries ME, Deng S et al. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection. Nat Med 2000; 6: 549-555.
9. Mele TS, Kneteman NM, Zhu L-F et al. IFN-γ is an absolute requirement for spontaneous acceptance of liver allografts. Am J Transplant 2003; 3: 942-951.
10. Ohmori Y, Hamilton TA. IFN-γ selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages. J Immunol 1994; 153: 2204-2212.
11. Melrose J, Tsurushita N, Liu G, Berg EL. IFN-γ inhibits activation-induced expression of E- and P-selectin on endothelial cells. J Immunol 1998; 161: 2457-2464.
12. + cells and CD40-CD40 ligand interactions. J Immunol 2001; 166: 3248-3255.
13. + T cells, interferon-gamma, and CTLA-4. J Clin Invest 1998; 101: 2446-2455.